A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia

PHASE2RecruitingINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

May 22, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Idiopathic Hypersomnia
Interventions
DRUG

ALKS 2680

Oral tablet containing ALKS 2680 for once daily administration

DRUG

Placebo

Oral placebo tablet for once daily administration

Trial Locations (40)

2113

RECRUITING

Alkermes Investigator Site, Sydney

3570

RECRUITING

Alkermes Investigator Site, Alken

5042

RECRUITING

Alkermes Investigator Site, Bedford Park

5101

RECRUITING

Alkermes Investigator Site, Namur

19610

RECRUITING

Alkermes Investigational Site, Wyomissing

28036

RECRUITING

Alkermes Investigator Site, Madrid

28037

RECRUITING

Alkermes Investigational Site, Denver

28043

RECRUITING

Alkermes Investigator Site, Madrid

28078

RECRUITING

Alkermes Investigational Site, Huntersville

29201

RECRUITING

Alkermes Investigational Site, Columbia

30281

RECRUITING

Alkermes Investigator Site, Stockbridge

30328

RECRUITING

Alkermes Investigational Site, Atlanta

31210

RECRUITING

Alkermes Investigator Site, Macon

32789

RECRUITING

Alkermes Investigator Site, Winter Park

33176

RECRUITING

Alkermes Investigator Site, Miami

33511

RECRUITING

Alkermes Investigational Site, Brandon

RECRUITING

Alkermes Investigator Site, Brandon

35055

RECRUITING

Alkermes Investigator Site, Cullman

37134

RECRUITING

Alkermes Investigator Site, Verona

40139

RECRUITING

Alkermes Investigator Site, Bologna

44195

RECRUITING

Alkermes Investigator Site, Cleveland

44718

RECRUITING

Alkermes Investigator Site, Canton

45245

RECRUITING

Alkermes Investigational Site, Cincinnati

48911

RECRUITING

Alkermes Investigational Site, Lansing

53792

RECRUITING

Alkermes Investigator Site, Madison

61637

RECRUITING

Alkermes Investigator Site, Peoria

68506

RECRUITING

Alkermes Investigational Site, Lincoln

72211

RECRUITING

Alkermes Investigator Site, Little Rock

77478

RECRUITING

Alkermes Investigator Site, Sugar Land

RECRUITING

Alkermes Investigator Site, Sugarland

78229

RECRUITING

Alkermes Investigational Site, San Antonio

78731

RECRUITING

Alkermes Investigational Site, Austin

80918

RECRUITING

Alkermes Investigational Site, Colorado Springs

85054

RECRUITING

Alkermes Investigator Site, Phoenix

90025

RECRUITING

Alkermes Investigator Site, Los Angeles

94063

RECRUITING

Alkermes Investigator Site, Redwood City

94143

RECRUITING

Alkermes Investigator Site, San Francisco

07748

RECRUITING

Alkermes Investigator Site, Middletown

128 21

RECRUITING

Alkermes Investigator Site, Prague

8025 BV

RECRUITING

Alkermes Investigator Site, Zwolle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alkermes, Inc.

INDUSTRY

NCT06843590 - A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia | Biotech Hunter | Biotech Hunter